期刊文献+

环氧化物水解酶基因多态性与新疆哈萨克族、汉族原发性高血压的相关性研究 被引量:2

Relationship between EPHX2 gene polymorphism and essential hypertension in Kazaks and Hans in Xinjiang
原文传递
导出
摘要 目的 探讨环氧化物水解酶( EPHX2)基因rs751141位点基因多态性与新疆哈萨克族、汉族原发性高血压之间的相关性.方法 分别选择新疆哈萨克族267例,汉族原发性高血压患者368例,同时选取哈萨克族、汉族正常对照组284例和348例,用Hardy-Weinberg平衡检验样本群体代表性,采用TaqMan探针法对EPHX2基因rs751141位点基因多态性进行检测.结果 新疆汉族原发性高血压组rs751141G/A多态位点GA+ AA基因型的分布频率(40.2%)明显低于正常对照组(52.0%),差异具有统计学意义(P<0.01),而新疆哈萨克族原发性高血压组与正常对照组中rs751141G/A基因多态性比较差异均无统计学意义(P>0.05).结论 EPHX2基因rs751141 G/A等位基因多态性与新疆哈萨克族原发性高血压无显著相关性,EPHX2基因rs751141G/A等位基因多态性与新疆汉族原发性高血压均显著相关,EPHX2基因rs751141位点的A等位基因可能是新疆汉族原发性高血压病的独立的保护因子. Objective To investigate the association between rs751141 gene polymorphisms in EPHX2 gene and essential hypertension in Kazak and Han in Xinjiang.MethodsA total of 267 essential hypertensive patients in Kazaks,368 essential hypertensive patients in Hans,284 normotensive controls in Kazaks and 348 normotensive controls in Hans were enrolled in this study.TaqMan assay was used to detect the rs751141 G/A gene polymorphisms of EPHX2 gene.Results The rs751141 G/A genotype frequencies for GA + AA genotypes was 40.2 percent in essential hypertensive subjects and 52.0 percent in control subjects in Hans,respectively.The genotype frequencies were significant difference between the two groups in Hans in Xinjiang( P 〈 0.01 ).The rs751141G/A gene polymorphism had no significant difference between essential hypertensive patients and normotensive controls in Kazaks in Xinjiang(P〉0.05).Conclusion The essential hypertension in Kazaks in Xinjiang is not associated with rs751141G/A gene polymorphism of EPHX2 gene,but the essential hypertension in Hans in Xinjiang is associated with rs751141G/A allele gene polymorphism of EPHX2 gene.A type of rs751141 allele gene polymorphism may be the independent protective factor of essential hypertension in Hans in Xiniiang.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第12期1101-1104,共4页 Chinese Journal of Cardiology
基金 基金项目:国家自然科学基金-地区科学基金项目(30760216)
关键词 高血压 环氧化物 基因 多态性 单核苷酸 Hypertension Epoxy compounds Genes Polymorphism, single nucletide
  • 相关文献

参考文献12

  • 1Puddu P,Puddu GM,Cravero E,et al.The geneticbasis of essential hypertension.Acta Cardio1,2007,62:281-293.
  • 2Newman JW,Morisseau C,Hammock BD.Epoxide hydrolases:their roles and interactions with lipid metabolism.Prog Lipid Res,2005,44:1-51.
  • 3Yu Z,Xu F,Huse LM,et al.Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.Circ Res,2000,87:992-998.
  • 4Spector AA,Fang X,Snyder GD,et al.Epoxyeicosatrienoic acids (EETs):metabolism and biochemical function.Prog Lipid Res,2004,43:55-90.
  • 5Koerner IP,Jacks R,DeBarber AE,et al.Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.J Neurosci,2007,27:4642-4649.
  • 6Hecker M,Bara AT,Bauersachs J,et al.Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.J Physiol,1994,481:407-414.
  • 7张腊喜,王焱燚,严江涛,汪道文.CYP2J2基因和EPHX2基因多态性与缺血性脑卒中的遗传易感性[J].临床内科杂志,2007,24(9):638-640. 被引量:7
  • 8Jung O,Brandes RP,Kim IH,et al.Soluble epoxide hydrolase is a main effector of angiotensin Ⅱ-induced hypertension.Hypertension,2005,45:759-765.
  • 9Yu Z,Davis BB,Morisseau C,et al.Vascular localization of soluble epoxide hydrolase in the human kidney.Am J Physiol Renal Physio1,2004,286:F720-F726.
  • 10Chacos N,Capdevila J,Falck JR,et al.The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase.Arch Biochem Biophys,1983,223:639-648.

二级参考文献1

共引文献6

同被引文献17

  • 1张腊喜,王焱燚,严江涛,汪道文.CYP2J2基因和EPHX2基因多态性与缺血性脑卒中的遗传易感性[J].临床内科杂志,2007,24(9):638-640. 被引量:7
  • 2AI D, FU Y, GUO D, et al. Angiotensin ]1 up-regu- lates soluble epoxide hydrolase in vascular endotheli- um in vitro and in vivo[J]. Proc Natl Acad Sei,2007, 104:9018-9023.
  • 3JUNG O, BRANDES R P, KIM I H, et al. Soluble ep oxide hydrolase is a main effector of angiotensin 11 induced hypertension[J]. Hypertension, 2005,45 : 759- 765.
  • 4ABDU E, BRUUN D A, YANG D, et al. Epoxyeico satrienoic acids enhance axonal growth in primary sen sory and cortical neuronal cell cultures[J]. J Neuro chemistry,2011,117 : 632- 642.
  • 5PRZYBYLA-ZAWISLAK B D, SRIVASTAVA P K, VAZQUEZ-MATIAS J, et al. Polymorphisms in hu man soluble epoxide hydrolase[J]. Mol Pharmacol, 2003,64:482-490.
  • 6NITHIPATIKOM K, GROSS G J. Review anticle= epoxyei- cosatrienoic acids: novel mediators of cardioprotection[J]. J Cardiovasc Pharmacol Ther, 2010,15 : 112- 119.
  • 7YANG S, WEI S, POZZI A, et al. The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis[J]. Arch Biochem Biophys, 2009,489 : 82 - 91.
  • 8NEWMAN J W, MORISSEAU C, HAMMOCK B [). Epoxide hydrolases., their roles and interactions with lipid metabolism[J]. Prog Lipid Res,2005,44:l 51.
  • 9SKEPNER J E, SHELLY L D, Jl C, et al. Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes [J]. Prostaglandins Other Lipid Mediat,2011,94 :,3 8.
  • 10IMIG J D, ZHAO X, CAPDEVILA J H, et al. Solu- ble epoxide hydrolase inhibition lowers arterial blood presssure in angiotensin ]I hypertension[Jj. Hyper- tension, 2002,39 : 690- 684.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部